EUVIMEDEUVIMED entdecken
Fallbericht

Role of individual factor X concentrate pharmacokinetic studies in perioperative management of AL amyloidosis‐associated acquired factor X deficiency

Akeem R Lewis iD, Nathan Peffley, Allan M Klompas iD, Aneel A Ashrani

Transfusion · 2023

DOI: 10.1111/trf.17477 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transfusion, 2023. Verfasst von Akeem R Lewis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Medicine, Mayo Clinic Rochester, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Immunoglobulin Light-chain Amyloidosis, Factor X Deficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

AL amyloidosis is associated with acquired factor X (FX) deficiency. Experience related to its management is limited to case reports and series using prothrombin complex concentrate, fresh frozen plasma, plasma exchange, recombinant activated factor seven, and desmopressin with limited and variable efficacy. FX concentrate has not been widely used in its management. Study Design and Methods We report our experience with the perioperative use of FX concentrate (Coagadex) in two patients with AL amyloidosis‐associated acquired FX deficiency requiring surgery, using their individual pharmacokinetic studies to manage perioperative hemostasis. Pharmacokinetic studies involved obtaining post‐infusion FX activity at 10 min, 2, and 4 h following the administration of FX concentrate to calculate the FX half‐life.

Results

Both patients' plasma FX activity was successfully increased to provide perioperative hemostatic support. Monitoring FX activity post‐surgery was also utilized to maintain FX activity levels to prevent post‐operative bleeding.

Conclusion

Pharmacokinetic studies have a useful role in tailoring preoperative FX repletion in patients with AL amyloidosis associated with acquired FX deficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin Light-chain AmyloidosisFactor X DeficiencyHumansFactor XPostoperative Hemorrhage

Stichwörter der Autor:innen

AL amyloidosisacquired factor X deficiencybleeding

Substanzen

Factor X

Autor:innen und Institutionen

  • Division of Hematology, Department of Medicine, Mayo Clinic Rochester, Rochester, Minnesota, USA.
  • Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Special Coagulation Laboratory, Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

ORCID-Profile: Akeem R Lewis, Allan M Klompas

Zitieren

APA

Lewis, A. R., Peffley, N., Klompas, A. M., & Ashrani, A. A. (2023). Role of individual factor X concentrate pharmacokinetic studies in perioperative management of AL amyloidosis‐associated acquired factor X deficiency. Transfusion. https://doi.org/10.1111/trf.17477

Vancouver

Lewis AR, Peffley N, Klompas AM, Ashrani AA. Role of individual factor X concentrate pharmacokinetic studies in perioperative management of AL amyloidosis‐associated acquired factor X deficiency. Transfusion. 2023. doi:10.1111/trf.17477

BibTeX
@article{Lewis2023,
  author = {Lewis, Akeem R and Peffley, Nathan and Klompas, Allan M and Ashrani, Aneel A},
  title = {Role of individual factor X concentrate pharmacokinetic studies in perioperative management of AL amyloidosis‐associated acquired factor X deficiency},
  journal = {Transfusion},
  year = {2023},
  doi = {10.1111/trf.17477}
}
Kostenlos starten →